AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
The GAO found it takes 11 years from an initial idea to delivery for many of the DOD's major acquisitions programs.
Through Aerospace & Defense Insights, we share with you the top legal and political issues affecting the aerospace and defense (A&D) industry.
Getting the right technology and data is imperative for driving DoD transformation initiatives, says Maximus’ Bryan Martz.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results